Malaysia has emerged as a major investment destination for biotech companies. The Malaysian biotech market posted high growth last year and is expected to do the same in next few years. Rich biodiversity, availability of low cost human resources and strong government efforts are some of the reasons that have boosted growth in the market. According to our new research report 'Emerging Biotech Sector in Malaysia', the biotech market in Malaysia is expected to grow at a CAGR of around 21% during 2010-2012. We have studied the Malaysian biotech market by breaking it into three segments - healthcare biotech, agriculture biotech and industrial biotech. Each of these segments has been extensively covered in the report, giving in-depth analysis of the current and future market trends along with valuable data of past trends. Our report also provides a complete overview of regulatory environment for the biotech market.Our report has found that increasing prevalence of diseases and rising exports of drugs from Malaysia are driving growth in the healthcare biotechnology market. This segment holds the highest potential for growth and will post the fastest growth rate among all the three segments. Besides, the country's expertise in agriculture sector will give strong impetus to the growth of this segment in near future whereas surging exports of biofuels and palm oil will boost the industrial biotech segment. Moreover, our report also provides a complete overview of restraints that are blocking growth in the industry coupled with certain useful recommendations, which will be useful for both government and clients in future prospects.The report studies the current development process and its effects on various segments of the industry. The research study gives detailed statistical and analytical information of macroeconomic indicators, key drivers and restraints. It also contains brief overview of government initiatives and key industry players that will help clients to draw up market strategies and assess areas of opportunity in the Malaysian biotech market.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Emerging Biotech Sector in Malaysia
Published on November 2009
Report Summary
Malaysia has emerged as a major investment destination for biotech companies. The Malaysian biotech market posted high growth
last year and is expected to do the same in next few years. Rich biodiversity, availability of low cost human resources and strong
government efforts are some of the reasons that have boosted growth in the market. According to our new research report 'Emerging
Biotech Sector in Malaysia', the biotech market in Malaysia is expected to grow at a CAGR of around 21% during 2010-2012.
We have studied the Malaysian biotech market by breaking it into three segments - healthcare biotech, agriculture biotech and
industrial biotech. Each of these segments has been extensively covered in the report, giving in-depth analysis of the current and
future market trends along with valuable data of past trends. Our report also provides a complete overview of regulatory environment
for the biotech market.
Our report has found that increasing prevalence of diseases and rising exports of drugs from Malaysia are driving growth in the
healthcare biotechnology market. This segment holds the highest potential for growth and will post the fastest growth rate among all
the three segments. Besides, the country's expertise in agriculture sector will give strong impetus to the growth of this segment in
near future whereas surging exports of biofuels and palm oil will boost the industrial biotech segment. Moreover, our report also
provides a complete overview of restraints that are blocking growth in the industry coupled with certain useful recommendations,
which will be useful for both government and clients in future prospects.
The report studies the current development process and its effects on various segments of the industry. The research study gives
detailed statistical and analytical information of macroeconomic indicators, key drivers and restraints. It also contains brief overview of
government initiatives and key industry players that will help clients to draw up market strategies and assess areas of opportunity in
the Malaysian biotech market.
Table of Content
1. Analyst View
2. Research Methodology
3. Biotechnology Industry
3.1 Market Overview
3.2 Market Segments
3.2.1 Healthcare Biotechnology
3.2.2 Agricultural Biotechnology
3.2.3 Industrial Biotechnology
4. Key Market Attraction
4.1 Rich Biodiversity
4.2 Low Cost Manufacturing
4.3 Biotech Education Infrastructure
5. Regulatory Environment
6. Government Initiatives
Emerging Biotech Sector in Malaysia Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
7. Industry Roadblocks and RNCOS Recommendations
7.1 Lack of Human Resources
7.2 Insufficient Funding
7.3 Distribution Network
7.4 Dependency on Import for Raw Materials
8. Key Players
8.1 Foreign Players
8.2 Domestic Players
List of Figures:
Figure 3-1: Biotechnology Market (Million RM), 2007-2012
Figure 3-2 Investments in Biotechnology Market by Segment (%), 2008
Figure 3-3: Pharmaceutical Market (Million US$), 2007-2012
Figure 3-4: Global - Biodiesel Demand ('000 Metric Tons), 2009-2011
Figure 4-1: Educational Institutions Offering Degree in Biotechnology
Figure 4-2: Educational Institutions Offering Master's Degree in Biotechnology
Figure 4-3: Educational Institutions Offering PhD in Biotechnology
List of Tables:
Table 3-1: Some Major Healthcare Biotechnology Companies
Table 3-2: Some Local and International Collaboration (2009)
Table 3-3: Some Major Agricultural Biotechnology Companies
Table 3-4: Bio-catalysts Isolated from Micro-organisms
Table 3-5: Research Projects in Industrial Biotechnology Sector
Table 3-6: Progress Specific to Industrial Biotechnology Sector
Table 4-1: Some Newly Discovered Floras and their Therapeutic Uses
Table 4-2: Comparison of Factors Affecting Biotechnology Industry among Different Countries
Table 6-1: The Nine Thrusts of the National Biotechnology Policy
Emerging Biotech Sector in Malaysia Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Emerging Biotech Sector in Malaysia
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 100.00 Quantity: _____
Hard Copy--USD 1 300.00 Quantity: _____
CD-ROM--USD 1 300.00 Quantity: _____
Corporate License--USD 1 800.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Emerging Biotech Sector in Malaysia Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Emerging Biotech Sector in Malaysia Page 4/4